FindTrial
Sign In

A study to look at the benefit of a radical treatment approach in advanced head and neck cancer as across a palliative approach.

Pragmatic patient choice-driven cohort study for staged radical approach in marginally operable and inoperable oral cavity squamous cell carcinoma. - nil

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/10/058737
Enrollment
100
Registered
2023-10-17
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-C14- Malignant neoplasms of lip, oral cavity and pharynx

Interventions

Intervention1: nil: nil Control Intervention1: nil: nil

Sponsors

Varian Medical Systems Inc
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with Inoperable/Marginally resectable Oral cavity malignancy - Buccal Mucosa and Oral Tongue.2.All such patients must be discussed in the multidisciplinary tumor board meeting and offered palliation.

Exclusion criteria

Exclusion criteria: 1. Medical and general condition precludes Radical approach 2. Patients with systemic metastasis

Design outcomes

Primary

MeasureTime frame
1 year survival rate, 2 year survival rate, overall survival, quality of life at each pointTimepoint: 1 year, 2 year and till death as all patients are very advanced in malignancy.—

Secondary

MeasureTime frame
1. Local progression 2. Distant Metastasis free survival 3. Overall metastasis 4. Cancer specific survival Timepoint: Follow up for 2 years.—

Countries

India

Contacts

Public ContactDr Balukrishna S

Christian Medical College, Vellore

balunair@cmcvellore.ac.in9626262296

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026